Madrigal Pharmaceuticals Inc (MDGL)

308.71 +15.30 (+5.21%) USD  |  NASDAQ  |  Dec 20, 16:00
307.91 -0.80 (-0.26%) After-Hours: 20:00
More

Madrigal Pharmaceuticals Max Drawdown (5Y): 82.20% for Nov. 30, 2024

Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for MDGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Max Drawdown Definition

View Max Drawdown Definition
Start Trial

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Corcept Therapeutics Inc 60.35%
89bio Inc 95.00%
ADMA Biologics Inc 84.77%
Matinas BioPharma Holdings Inc 99.54%
Viking Therapeutics Inc 89.26%

Max Drawdown (5Y) Related Metrics

Alpha (5Y) 27.46
Beta (5Y) -0.4182
Annualized Standard Deviation of Monthly Returns (5Y Lookback) 159.1%
Historical Sharpe Ratio (5Y) 0.1375
Historical Sortino (5Y) 0.839
Monthly Value at Risk (VaR) 5% (5Y Lookback) 22.13%